06/01/2022
Selina Vlieger, MSc; Jin M. Cheng, MD, PhD; Rohit M. Oemrawsingh, MD, PhD; Auke P.J.D. Weevers, MD; Jawed Polad, MD; Ben Gho, MD, PhD; Martijn Meuwissen, MD, PhD; Eric Boersma, PhD; Peter den Heijer, MD, PhD; Alexander JJ. IJsselmuiden, MD, PhD
Randomized controlled trials for in-stent restenosis (ISR) and de novo lesions in small-diameter vessels have shown promising results, but data on DCB use in real-world practice are still scarce. The aim of the PEARL (Paclitaxel-Eluting...
Randomized controlled trials for in-stent restenosis (ISR) and de novo lesions in small-diameter vessels have shown promising results, but data on DCB use in real-world practice are still scarce. The aim of the PEARL (Paclitaxel-Eluting...
Randomized controlled trials for...